Parameters of Blood Count and Tumor Markers in Patients with Borderline Ovarian Tumors: A Retrospective Analysis and Relation to Staging

Table 3

Increased tumour markers (𝑛/total of cases) in relation to groups of stages.

	Stage IA	%	Stages IB-IIIC	%
CA-125 (≥35 U/mL)	2/10	20	4/6	66.7
CA-15.3 (≥25 U/mL)	4/10	40	2/6	33.3
CA-19.9 (≥39 U/mL)	1/10	10	4/6*	66.7
CEA (≥5.5 ng/mL)	1/11	9.1	6/6**	100
AFP (≥12.1 ng/mL)	0/11	0	0/5	0

Fisher’s exact test. *, **, respectively, 𝑃<0.0357 and 0.0006, compared to stage I.